| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |